Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination
- PMID: 36265005
- PMCID: PMC9746413
- DOI: 10.1080/21645515.2022.2132755
Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination
Abstract
The delivery of strong HPV vaccine recommendations hinges on the expertise of healthcare providers (HCPs) in assessing patients' status and recommending HPV vaccination. We conducted a population-based cross-sectional study of HCPs practicing in Texas to examine the relationship between HPV vaccination training of HCPs and HPV vaccination status assessment and recommendation. Logistic regression analyses were used to assess the association between HCPs' formal training and recency of training in HPV vaccination promotion or counseling with HPV vaccination status assessment and recommendation. Of the 1,283 HCPs who completed the online survey, 43% had received training in HPV vaccination promotion or counseling, 47% often/always assess HPV vaccination status, and 59% often/always recommend HPV vaccination. Compared with HCPs who received no training, those who received training had over four times higher odds (adjusted odds ratio [AOR]: 4.32; 95% CI: 3.06-6.10) of often/always assessing HPV vaccination status and over three and half times higher odds (AOR: 3.66; 95% CI: 2.73-4.90) of often/always recommending HPV vaccination. Furthermore, HCPs who recently received HPV vaccination training had higher odds of HPV vaccination status assessment and recommendations than those without training. Hispanic HCPs had higher odds of often/always assessing HPV vaccination status and recommending vaccination than did non-Hispanic White HCPs. Also, nurses and physician assistants had lower odds of often/always assessing HPV vaccination status and recommending HPV vaccination than did physicians. Targeted and continuous training of HCPs in HPV vaccination promotion or counseling is needed to increase HPV vaccination status assessment, recommendation, and uptake rates.
Keywords: HPV vaccination assessment; HPV vaccination recommendation; HPV vaccines; Human papillomavirus; Training.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures
Similar articles
-
Factors that Influence Healthcare Provider Recommendation of HPV Vaccination.Am J Health Promot. 2022 Sep;36(7):1152-1161. doi: 10.1177/08901171221091438. Epub 2022 Apr 20. Am J Health Promot. 2022. PMID: 35442819 Free PMC article.
-
Human papillomavirus vaccination related knowledge, and recommendations among healthcare providers in Southern China: a cross-sectional survey.BMC Womens Health. 2022 May 14;22(1):169. doi: 10.1186/s12905-022-01728-8. BMC Womens Health. 2022. PMID: 35568870 Free PMC article.
-
Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents.Vaccine. 2017 Feb 1;35(5):802-807. doi: 10.1016/j.vaccine.2016.12.045. Epub 2017 Jan 4. Vaccine. 2017. PMID: 28063706 Free PMC article.
-
A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in China.Prev Med. 2021 May;146:106484. doi: 10.1016/j.ypmed.2021.106484. Epub 2021 Feb 26. Prev Med. 2021. PMID: 33647350
-
HPV Vaccination Training of Healthcare Providers and Perceived Self-Efficacy in HPV Vaccine-Hesitancy Counseling.Vaccines (Basel). 2022 Nov 26;10(12):2025. doi: 10.3390/vaccines10122025. Vaccines (Basel). 2022. PMID: 36560435 Free PMC article.
Cited by
-
Barriers to human papillomavirus vaccine uptake: role of state religiosity and healthcare professionals' participation in a state vaccine program.JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad068. doi: 10.1093/jncics/pkad068. JNCI Cancer Spectr. 2023. PMID: 37698997 Free PMC article.
-
Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities.Hum Vaccin Immunother. 2023 Aug;19(2):2264596. doi: 10.1080/21645515.2023.2264596. Epub 2023 Oct 17. Hum Vaccin Immunother. 2023. PMID: 37846730 Free PMC article.
-
Evaluating implementation by rural clinics of evidence-based interventions to promote HPV vaccination.J Rural Health. 2025 Jan;41(1):e70006. doi: 10.1111/jrh.70006. J Rural Health. 2025. PMID: 39962360 Free PMC article.
-
Healthcare Provider's Perceived Self-Efficacy in HPV Vaccination Hesitancy Counseling and HPV Vaccination Acceptance.Vaccines (Basel). 2023 Jan 30;11(2):300. doi: 10.3390/vaccines11020300. Vaccines (Basel). 2023. PMID: 36851178 Free PMC article.
-
Barriers to the assessment and recommendation of HPV vaccination among healthcare providers in Texas.Vaccine X. 2024 Mar 13;18:100471. doi: 10.1016/j.jvacx.2024.100471. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38523619 Free PMC article.
References
-
- Meites E, Gee J, Unger E, Markowitz, L.. Human papillomavirus. In: Hamborsky J, editor. Epidemiology and prevention of vaccine-preventable diseases. 13th ed.; 2015. p. 1–8. https://www.cdc.gov/vaccines/pubs/pinkbook/hpv.html#hpv
-
- Centers for Disease Control and Prevention . Genital HPV infection - fact sheet; 2022. Jan 3 [assessed 2022 Feb 14]. https://www.cdc.gov/std/hpv/stdfact-hpv.htm
-
- Chesson HW, Ekwueme DU, Saraiya M, Watson M, Lowy DR, Markowitz LE. Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States. Vaccine. 2012;30(42):6016–19. doi:10.1016/j.vaccine.2012.07.056. - DOI - PMC - PubMed
-
- CPRIT . An economic assessment of the cost of cancer in Texas and the benefits of the cancer prevention and research institute of Texas (CPRIT) and its programs: 2020 update; 2020. [accessed 2021 Nov 29]. https://www.cprit.state.tx.us/media/2456/perryman_cprit_impact_2020-0121...
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources